Pergolide monotherapy for Parkinson's disease.
van der Worp
B
B
Department of Neurology, University Medical Centre, Utrecht, The Netherlands. H.B.vandeWorp@neuro.azu.nl
D018491:Dopamine Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010479:Pergolide / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D018491:Dopamine Agonists; D010479:Pergolide